G
Gary S. Wood
Researcher at University of Wisconsin-Madison
Publications - 223
Citations - 16551
Gary S. Wood is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Mycosis fungoides & Antigen. The author has an hindex of 63, co-authored 221 publications receiving 15706 citations. Previous affiliations of Gary S. Wood include United States Department of Veterans Affairs & University Hospitals of Cleveland.
Papers
More filters
Journal ArticleDOI
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
Elise A. Olsen,Eric C. Vonderheid,Nicola Pimpinelli,Rein Willemze,Youn H. Kim,Robert Knobler,Herschel S. Zackheim,Madeleine Duvic,Teresa Estrach,Stanford I. Lamberg,Gary S. Wood,Reinhard Dummer,Annamari Ranki,Günter Burg,Peter Heald,Mark R. Pittelkow,M.G. Bernengo,Wolfram Sterry,Liliane Laroche,Franz Trautinger,Sean Whittaker +20 more
TL;DR: These revisions are made to incorporate advances related to tumor cell biology and diagnostic techniques as pertains to mycosis fungoides and Sézary syndrome to clarify certain variables that currently impede effective interinstitution and interinvestigator communication and/or the development of standardized clinical trials in MF and SS.
Journal ArticleDOI
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
Elise A. Olsen,Madeleine Duvic,Arthur E. Frankel,Youn H. Kim,Ann Martin,Eric C. Vonderheid,Brian V. Jegasothy,Gary S. Wood,Michael S. Gordon,Peter W. Heald,Allan Oseroff,Lauren C. Pinter-Brown,Glen Bowen,Timothy M. Kuzel,David P. Fivenson,Francine M. Foss,Michael Glode,Arturo Molina,Elizabeth Knobler,Stanford J. Stewart,Kevin D. Cooper,Seth R. Stevens,Fiona E. Craig,James M. Reuben,Patricia Bacha,Jean Nichols +25 more
TL;DR: Denileukin diftitox has been shown to be a useful and important agent in the treatment of patients whose CTCL is persistent or recurrent despite other therapeutic interventions.
Journal ArticleDOI
Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems.
Gary S. Wood,Roger A. Warnke +1 more
TL;DR: Utilizing this method, endogenous avidin-binding activity was detected and suppressed in selected human and murine tissues, thus facilitating the interpretation of specific immunohistochemical staining utilizing hybridoma monoclonal antibodies in a biotin-avidin-horseradish peroxidase detection system.
Journal ArticleDOI
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.
Elise A. Olsen,Sean Whittaker,Youn H. Kim,Madeleine Duvic,H. Miles Prince,Stuart R. Lessin,Gary S. Wood,Rein Willemze,Marie-France Demierre,Nicola Pimpinelli,Maria Grazia Bernengo,Pablo L. Ortiz-Romero,Martine Bagot,Teresa Estrach,Joan Guitart,Robert Knobler,José Antonio Sanches,Keiji Iwatsuki,Makoto Sugaya,Reinhard Dummer,Mark R. Pittelkow,Richard T. Hoppe,Sareeta Parker,Larisa J. Geskin,Lauren Pinter-Brown,Michael Girardi,Guenter Burg,Annamari Ranki,Maartan Vermeer,Steven M. Horwitz,Peter Heald,Steve Rosen,Lorenzo Cerroni,B. Dréno,Eric C. Vonderheid +34 more
TL;DR: In this article, consensus recommendations for the general conduct of clinical trials of patients with mycosis fungoides (MF) and Sezary syndrome (SS), as well as methods for standardized assessment of potential disease manifestations in skin, lymph nodes, blood, and visceral organs, were presented.
Journal ArticleDOI
Defining early mycosis fungoides.
Nicola Pimpinelli,Elise A. Olsen,Marco Santucci,Eric C. Vonderheid,Andreas C. Haeffner,Seth R. Stevens,Guenter Burg,Lorenzo Cerroni,Brigitte Dréno,Earl J. Glusac,Joan Guitart,Peter Heald,Werner Kempf,Robert Knobler,Stuart R. Lessin,Christian A. Sander,Bruce S. Smoller,Gladys H. Telang,Sean Whittaker,Keiji Iwatsuki,Erik Obitz,Masahiro Takigawa,Maria L. Turner,Gary S. Wood +23 more
TL;DR: It is anticipated that a more standardized approach to the diagnosis of early mycosis fungoides will have a beneficial impact on the epidemiology, prognostication, treatment, and analysis of clinical trials pertaining to this most common type of cutaneous lymphoma.